Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris

被引：5
|
作者：
Brumfiel, Caitlin M. [1 ]
Patel, Meera H. [2 ]
Bell, Katheryn A. [1 ]
Cardis, Michael A. [3 ]
机构：
[1] Georgetown Univ, Sch Med, 3900 Reservoir Rd, Washington, DC 20007 USA
[2] Creighton Univ, Sch Med, Phoenix Reg Campus, Phoenix, AZ USA
[3] Georgetown Univ Hosp, MedStar Washington Hosp Ctr, Dept Dermatol, Washington, DC 20007 USA
来源：
THERAPEUTICS AND CLINICAL RISK MANAGEMENT | 2021年 / 17卷
关键词：
acne vulgaris; trifarotene; retinoid; randomized controlled trials; RETINOIDS; ADOLESCENTS; MANAGEMENT;
D O I：
10.2147/TCRM.S286953
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Acne vulgaris is a common skin condition of the face and trunk that negatively impacts quality of life. Trifarotene is a new first-in-class fourth-generation topical retinoid that has been uniquely studied in the treatment of both facial and truncal acne. Through selective agonism of retinoic acid receptor (RAR)-gamma, the most predominant RAR isotype in the epidermis, trifarotene exerts more targeted, skin-specific effects than earlier generation retinoids. This narrative review summarizes all currently available literature regarding the use of trifarotene in acne vulgaris. We focus on efficacy, safety, and tolerability data and highlight quality of life outcomes and patient-reported satisfaction. Future clinical trials and the clinical applicability of this novel medication in the treatment of acne are also discussed.
引用
收藏
页码：755 / 763
页数：9
相关论文
共 50 条
  • [31] Efficacy of oral isotretinoin in the treatment of acne vulgaris
    Bin Al-Zou, Amer
    Saleh, Asia Hassan Abdulla
    Bafadhl, Mohamed Saeed
    Elkasah, Fathi
    WORLD FAMILY MEDICINE, 2022, 20 (09): : 41 - 50
  • [32] Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series
    James Q. Del Rosso
    Edward Lain
    Jean Philippe York
    Andrew Alexis
    Dermatology and Therapy, 2022, 12 : 2189 - 2200
  • [33] Safety and Efficacy of Low-Dose Isotretinoin in the Treatment of Moderate to Severe Acne Vulgaris
    Rao, Parinitha K.
    Bhat, Ramesh M.
    Nandakishore, B.
    Dandakeri, Sukumar
    Martis, Jacintha
    Kamath, Ganesh H.
    INDIAN JOURNAL OF DERMATOLOGY, 2014, 59 (03) : 316
  • [34] Efficacy and safety of topical spironolactone 5% gel versus placebo in the treatment of acne vulgaris
    Attwa, Enayat M.
    Ibrahim, Al Shimaa M.
    Abd El-Halim, Marwa F.
    Mahmoud, Hanan M.
    EGYPTIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2019, 39 (02): : 89 - 94
  • [35] Efficacy and safety of intense pulsed light in the treatment of inflammatory acne vulgaris with a novel filter
    Chen, Sunyi
    Wang, Yan
    Ren, Jie
    Yue, Baishuang
    Lai, Guanyin
    Du, Juan
    JOURNAL OF COSMETIC AND LASER THERAPY, 2019, 21 (06) : 323 - 327
  • [36] Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series
    Del Rosso, James Q.
    Lain, Edward
    York, Jean Philippe
    Alexis, Andrew
    DERMATOLOGY AND THERAPY, 2022, 12 (09) : 2189 - 2200
  • [37] Phase 2 study of efficacy and safety of SB204 in the treatment of acne vulgaris
    Rico, J.
    Quiring, J.
    Hollenbach, S.
    Enloe, C.
    Stasko, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (08) : S8 - S8
  • [38] Subject Satisfaction with Trifarotene 50 μg/g Cream in the Treatment of Facial and Truncal Acne Vulgaris: A Case Series
    Sandra M. Johnson
    Rajeev Chavda
    Janet C. DuBois
    Dermatology and Therapy, 2020, 10 : 1165 - 1173
  • [39] Subject Satisfaction with Trifarotene 50 μg/g Cream in the Treatment of Facial and Truncal Acne Vulgaris: A Case Series
    Johnson, Sandra M.
    Chavda, Rajeev
    DuBois, Janet C.
    DERMATOLOGY AND THERAPY, 2020, 10 (05) : 1165 - 1173
  • [40] THE SAFETY OF TOPICAL ANTIBIOTICS IN THE TREATMENT OF ACNE-VULGARIS
    FISHER, AA
    CUTIS, 1980, 25 (05): : 474 - &
12345